Investor Relations

Esperion Therapeutics, Inc. is an emerging pharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-C) lowering therapies for the treatment of hypercholesterolemia and other cardiometabolic risk markers.

Esperion Therapeutics is a publicly traded company (since 2013) and is listed on the NASDAQ Global Select Market under the symbol ESPR.

Esperion Therapeutics (NASDAQ: ESPR) 4:00 PM ET on Nov 20, 2014
Last Price Change Open Day High 52-Week High
29.25
1.52  down   (4.940%) 30.50 30.50 34.42
Volume Previous Close Day Low 52-Week Low
270,000 30.77 28.06 10.90

View all »   RSSRecent Releases

Nov 12, 2014
Esperion Therapeutics to Present at Stifel 2014 Healthcare Conference

Nov 11, 2014
Esperion Therapeutics to Host and Webcast Live Investor Event